analyst
FT
NASDAQ · FTRE
Fortrea Holdings Inc.
Healthcare · Biotechnology
$17.70
Down-$0.92 (-4.94%)
Updated Sep 6, 2026, 9:41 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.4B
- P/E ratio
- -1.4
- Dividend yield
- 0.00%
- 52-week range
- $8.31 – $21.39
- Volume
- 762.08K
- Avg. volume
- 1.34M
Price performance
FTRE price history
1M range · 20 trading sessions · Daily adjusted prices
FTRE closed at $17.70 after 20 trading sessions, down 6.79% for the selected period.
- Last close
- $17.70
- Period change
- -6.79%
- Period low
- $17.41
- Period high
- $19.52
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $18.50 | $18.50 | $17.64 | $17.70 | 762.08K |
| Sep 3, 2026 | $18.67 | $18.99 | $18.18 | $18.62 | 776.31K |
| Sep 2, 2026 | $17.91 | $19.00 | $17.81 | $18.36 | 902.45K |
| Sep 1, 2026 | $18.38 | $18.51 | $17.62 | $17.72 | 1.19M |
| Aug 31, 2026 | $18.60 | $18.77 | $18.02 | $18.37 | 1.51M |
| Aug 28, 2026 | $18.765 | $19.14 | $18.46 | $18.81 | 1.14M |
| Aug 27, 2026 | $18.70 | $19.34 | $18.55 | $18.86 | 1.32M |
| Aug 26, 2026 | $18.10 | $18.55 | $17.99 | $18.53 | 598.3K |
| Aug 25, 2026 | $18.33 | $18.64 | $17.87 | $18.27 | 599.53K |
| Aug 24, 2026 | $18.34 | $18.45 | $17.78 | $18.31 | 1.05M |
| Aug 21, 2026 | $18.23 | $18.539 | $17.82 | $18.39 | 864.12K |
| Aug 20, 2026 | $17.88 | $18.765 | $17.87 | $18.19 | 1.52M |
| Aug 19, 2026 | $17.93 | $18.49 | $17.8675 | $18.14 | 1.03M |
| Aug 18, 2026 | $17.80 | $18.10 | $17.405 | $17.60 | 682.08K |
| Aug 17, 2026 | $17.37 | $18.12 | $17.15 | $18.10 | 1.15M |
| Aug 14, 2026 | $17.65 | $17.84 | $16.84 | $17.41 | 2.56M |
| Aug 13, 2026 | $18.52 | $18.68 | $17.71 | $17.82 | 1.33M |
| Aug 12, 2026 | $19.33 | $19.35 | $18.30 | $18.33 | 1.66M |
| Aug 11, 2026 | $18.94 | $19.585 | $18.82 | $19.52 | 869.37K |
| Aug 10, 2026 | $18.12 | $19.285 | $17.91 | $18.99 | 1.04M |
Latest FTRE news
The latest Smart Investors Daily articles mentioning FTRE.
Stock researchCompany · Financials
Loading stock research…